Skip to content

Medi-Trace 1310P Combination Defibrillation, Monitoring & Pacing Electrode

by Graphic Controls Corp.

510(k) K980857

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK980857 Date12 May 1998ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MKJ
Device Class
Class III
Regulation
21 CFR Part 870.5310
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Medi-Trace 1310P is a combination defibrillation, monitoring, and pacing electrode designed for use with automated external defibrillators (non-wearable). It integrates defibrillation, electrocardiogram (ECG) monitoring, and temporary cardiac pacing functions into a single electrode system, enabling comprehensive cardiac assessment and intervention during emergencies.

This device is supplied as a single-use, sterile electrode intended for pre-hospital and clinical settings. It is classified as a Class III medical device under FDA regulations (870.5310) and has received FDA 510(k) clearance (K980857) as substantially equivalent to the predicate device. Storage and handling must adhere to manufacturer guidelines to maintain sterility and functionality, ensuring readiness for immediate use in cardiac arrest or bradycardia scenarios.

Other devices from Graphic Controls Corp.

See all devices from Graphic Controls Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of emergencies is the Medi-Trace 1310P designed to address in pre-hospital and clinical settings?

    The Medi-Trace 1310P is specifically designed for cardiac emergencies requiring defibrillation, ECG monitoring, and temporary cardiac pacing. It is intended for use during cardiac arrest scenarios or bradycardia events where immediate intervention is critical, enabling comprehensive cardiac assessment and intervention through a single electrode system.

  • Is the Medi-Trace 1310P reusable or intended for single-use, and how should it be stored to maintain sterility?

    The Medi-Trace 1310P is a single-use, sterile electrode. To maintain sterility and functionality, storage and handling must strictly follow the manufacturer’s guidelines, ensuring it remains ready for immediate use in emergencies without compromising its sterile state.

  • What regulatory pathway was followed for FDA clearance of the Medi-Trace 1310P, and what classification does it hold?

    The Medi-Trace 1310P underwent a traditional 510(k) clearance process and was determined to be substantially equivalent to a predicate device. It is classified as a Class III medical device under FDA regulations (870.5310), reflecting its critical role in life-saving cardiac interventions.

  • Can this device be used with any automated external defibrillator (non-wearable), or is it compatible only with specific models?

    The Medi-Trace 1310P is designed for use with automated external defibrillators (non-wearable) in general, though compatibility should be confirmed with the specific defibrillator model in use. Its integrated design supports defibrillation, ECG monitoring, and temporary pacing, making it versatile for emergency cardiac care.